Nguyen Tan Van, Nguyen Tuan Dinh, Cao Dinh Hung, Nguyen Tuan Dinh, Ngo Trinh Thi Kim, Do Dung Viet, Le Thanh Dinh
Department of Geriatrics and Gerontology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Department of Interventional Cardiology, Thong Nhat Hospital, Ho Chi Minh City, Vietnam.
Front Med (Lausanne). 2024 Jul 4;11:1406007. doi: 10.3389/fmed.2024.1406007. eCollection 2024.
Older patients typically face elevated mortality rates and greater medical resource utilization during hospitalizations compared to their younger counterparts. Sarcopenia, serving as a prognostic indicator, is related to disability, diminished quality of life, and increased mortality. The SARC-F questionnaire, known for its cost-effectiveness, offers a valuable means of assessing sarcopenia. This study aims to explore the association between SARC-F scores and risk of adverse outcomes in elderly patients with cardiovascular disease at a Ho Chi Minh City hospital.
Participants aged 60 and above, admitted to the Department of Cardiology - Interventional and Cardiovascular Emergency of Thong Nhat Hospital in Ho Chi Minh City from November 2021 to June 2022, were recruited for the prospective, single-center study. The prognostic outcomes included all-cause death and the initial occurrence of emergency re-hospitalization within 6 months' post-discharge. The Kaplan-Meier analysis compared the overall survival rates between different SARC-F score groups.
The study enrolled 285 patients with a median age of 74 (67, 81). During a 6-month follow-up period, there were 14 cases of mortality. A SARC-F score of 4 or higher was significantly associated with an increased risk of all-cause mortality, with HR of 2.02 (95% CI: 1.39-2.92, < 0.001), and higher incidence of re-hospitalization events with RR of 1.66 (95% CI: 1.06 to 2.59, = 0.026). Kaplan-Meier survival analysis indicated a notably higher mortality rate in the patients with high SARC-F scores ( < 0.001).
In elderly patients with cardiovascular disease, the SARC-F questionnaire could serve as a simple and cost-effective method for detecting mortality and the risk of re-hospitalization.
与年轻患者相比,老年患者在住院期间通常面临更高的死亡率和更多的医疗资源利用。肌肉减少症作为一种预后指标,与残疾、生活质量下降和死亡率增加有关。以成本效益著称的SARC-F问卷为评估肌肉减少症提供了一种有价值的方法。本研究旨在探讨胡志明市一家医院老年心血管疾病患者的SARC-F评分与不良结局风险之间的关联。
招募2021年11月至2022年6月入住胡志明市统一医院心血管介入与心血管急诊科的60岁及以上患者进行这项前瞻性单中心研究。预后结局包括全因死亡和出院后6个月内首次发生的紧急再次住院。Kaplan-Meier分析比较了不同SARC-F评分组之间的总体生存率。
该研究纳入了285例患者,中位年龄为74岁(67岁,81岁)。在6个月的随访期内,有14例死亡病例。SARC-F评分为4分或更高与全因死亡率增加显著相关,风险比为2.02(95%置信区间:1.39 - 2.92,P < 0.001),再次住院事件的发生率更高,相对风险为1.66(95%置信区间:1.06至2.59,P = 0.026)。Kaplan-Meier生存分析表明,SARC-F评分高的患者死亡率显著更高(P < 0.001)。
在老年心血管疾病患者中,SARC-F问卷可作为一种简单且具有成本效益的方法来检测死亡率和再次住院风险。